Our research comprehensively investigates the anti-tumor effect of CUDC-907 in vitro and in vivo, suggesting the efficacious inhibition of CUDC-907 on the proliferation, migration, and invasion of esophageal cancer cells and the induction autophagy via mTOR inhibition and LCN2 downregulation. The gene discussed is LCN2; the disease is esophageal cancer.